Philipp Henneke Selected Research

Philipp Henneke Research Topics

Disease

15	Sepsis (Septicemia) 01/2020 - 05/2002
9	Infections 01/2023 - 02/2003
4	Neonatal Sepsis 01/2013 - 06/2006
2	Neoplasms (Cancer) 05/2024 - 07/2015
2	COVID-19 01/2022 - 01/2021
2	Mycoses (Diseases, Fungus) 05/2014 - 09/2003
2	Job Syndrome (Hyper-IgE Syndrome) 05/2014 - 01/2008
2	Bacterial Infections (Bacterial Infection) 07/2009 - 02/2007
2	Pneumococcal Infections 10/2005 - 02/2003
1	cell-associated neurotoxicity 05/2024
1	Late Onset Disorders 10/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Epilepsy (Aura) 01/2022
1	Cysts 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022
1	Human Influenza (Influenza) 01/2020
1	Dysbiosis 11/2019
1	Cytomegalovirus Infections (Inclusion Disease) 01/2017
1	Polyploidy 11/2016
1	Birth Weight (Birth Weights) 01/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2015
1	Exfoliative Dermatitis (Erythroderma) 10/2015
1	Neoplasm Metastasis (Metastasis) 07/2015
1	Ewing Sarcoma (Sarcoma, Ewing) 07/2015
1	Starvation 07/2015
1	Paramyxoviridae Infections (Parainfluenza) 09/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2014
1	Soft Tissue Infections 05/2014
1	Eczema 05/2014
1	Rheumatoid Arthritis 04/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2014
1	Inflammation (Inflammations) 07/2009
1	Meningitis 06/2009
1	Bacterial Meningitis 02/2007
1	MYD88 Deficiency 05/2004
1	Septic Shock (Toxic Shock Syndrome) 05/2004
1	Fever (Fevers) 09/2003
1	Chills 09/2003

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 01/2023 - 09/2003
6	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016 - 05/2002
4	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2002
3	Interleukin-6 (Interleukin 6)IBA 07/2015 - 05/2004
3	Streptococcus pneumoniae plY proteinIBA 01/2013 - 02/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 05/2004
2	ChemokinesIBA 01/2022 - 11/2012
2	LigandsIBA 01/2022 - 05/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2016
2	16S Ribosomal RNAIBA 01/2020 - 11/2019
2	Immunoglobulin E (IgE)IBA 10/2015 - 05/2014
2	Virulence Factors (Pathogenicity Factors)IBA 01/2014 - 01/2013
2	Lipoproteins (Lipoprotein)IBA 07/2009 - 05/2008
2	Toll-Like Receptor 4IBA 10/2005 - 02/2003
1	Chimeric Antigen ReceptorsIBA 05/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	Immunoglobulin A (IgA)IBA 11/2022
1	AntigensIBA 10/2022
1	Glutamate DehydrogenaseIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	LipidsIBA 01/2022
1	ABO Blood-Group SystemIBA 01/2022
1	AntibodiesIBA 01/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2015
1	RNA (Ribonucleic Acid)IBA 09/2014
1	Nucleic AcidsIBA 09/2014
1	DNA (Deoxyribonucleic Acid)IBA 05/2014
1	Codon (Codons)IBA 03/2014
1	Insulin (Novolin)FDA Link 11/2012
1	Differentiation AntigensIBA 06/2009
1	lipopolysaccharide-binding proteinIBA 02/2007
1	Interleukin-8 (Interleukin 8)IBA 02/2007
1	pyrazolanthroneIBA 03/2006
1	Phosphotransferases (Kinase)IBA 03/2006
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 10/2005
1	Amphotericin B (Amphotericin)FDA LinkGeneric 09/2003

Therapy/Procedure

7	Therapeutics 01/2017 - 01/2006
2	Antibiotic Prophylaxis 10/2023 - 05/2014
1	Immunotherapy 05/2024
1	Cell Transplantation 06/2014